FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1871-1877 June 13, 2002 Number 24 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Farr, B. M. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Patients with nasal carriage of Staphylococcus aureus have an increased risk of surgical-site infections caused by that organism. Treatment with mupirocin ointment can reduce the rate of nasal carriage and may prevent postoperative S. aureus infections.

Methods We conducted a randomized, double-blind, placebo-controlled trial to determine whether intranasal treatment with mupirocin reduces the rate of S. aureus infections at surgical sites and prevents other nosocomial infections.

Results Of 4030 enrolled patients who underwent general, gynecologic, neurologic, or cardiothoracic surgery, 3864 were included in the intention-to-treat analysis. Overall, 2.3 percent of mupirocin recipients and 2.4 percent of placebo recipients had S. aureus infections at surgical sites. Of the 891 patients (23.1 percent of the 3864 who completed the study) who had S. aureus in their anterior nares, 444 received mupirocin and 447 received placebo. Among the patients with nasal carriage of S. aureus, 4.0 percent of those who received mupirocin had nosocomial S. aureus infections, as compared with 7.7 percent of those who received placebo (odds ratio for infection, 0.49; 95 percent confidence interval, 0.25 to 0.92; P=0.02).

Conclusions Prophylactic intranasal application of mupirocin did not significantly reduce the rate of S. aureus surgical-site infections overall, but it did significantly decrease the rate of all nosocomial S. aureus infections among the patients who were S. aureus carriers.

Source Information

From the University of Iowa Colleges of Medicine and Public Health, Iowa City (T.M.P., J.J.C., R.P.W., M.B.Z., M.A.P., D.S., J.T., L.A.H.); the University of Iowa Hospitals and Clinics, Iowa City (L.A.H.); GlaxoSmithKline, Collegeville, Pa. (P.P.F.); and the Johns Hopkins Medical Institutions, Baltimore (T.M.P.).

Address reprint requests to Dr. Perl at the Johns Hopkins Medical Institutions, Division of Infectious Diseases and Department of Hospital Epidemiology and Infection Control, 425 Osler, Johns Hopkins Hospital, 600 N. Wolfe St., Baltimore, MD 21287.

Full Text of this Article

Related Letters:

Intranasal Mupirocin to Prevent Postoperative Infections
von Eiff C., Kipp F., Becker K., Delgado-Hachmeister J. E., Graviss E. A., Perl T. M., Zimmerman M. B.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:1207-1208, Oct 10, 2002. Correspondence

This article has been cited by other articles:

• Malani, P. N. (2009). Functional Status Assessment in the Preoperative Evaluation of Older Adults. JAMA 302: 1582-1583 [Full Text]  
• Meehan, J., Jamali, A. A., Nguyen, H. (2009). Prophylactic Antibiotics in Hip and Knee Arthroplasty. JBJS 91: 2480-2490 [Abstract] [Full Text]  
• Coates, T., Bax, R., Coates, A. (2009). Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother 64: 9-15 [Abstract] [Full Text]  
• Robicsek, A., Suseno, M., Beaumont, J. L., Thomson, R. B. Jr., Peterson, L. R. (2008). Prediction of Methicillin-Resistant Staphylococcus aureus Involvement in Disease Sites by Concomitant Nasal Sampling. J. Clin. Microbiol. 46: 588-592 [Abstract] [Full Text]  
• van Rijen, M. M. L., Bonten, M., Wenzel, R. P., Kluytmans, J. A. J. W. (2008). Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother 61: 254-261 [Abstract] [Full Text]  
• Gongora, E., Sundt, T. M. III (2008). Myocardial Revascularization with Cardiopulmonary Bypass. Card Surg Adult 3: 599-632 [Full Text]  
• Simor, A. E., Stuart, T. L., Louie, L., Watt, C., Ofner-Agostini, M., Gravel, D., Mulvey, M., Loeb, M., McGeer, A., Bryce, E., Matlow, A., and the Canadian Nosocomial Infection Surveillance, (2007). Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus Strains in Canadian Hospitals. Antimicrob. Agents Chemother. 51: 3880-3886 [Abstract] [Full Text]  
• Ellis, M. W., Griffith, M. E., Dooley, D. P., McLean, J. C., Jorgensen, J. H., Patterson, J. E., Davis, K. A., Hawley, J. S., Regules, J. A., Rivard, R. G., Gray, P. J., Ceremuga, J. M., DeJoseph, M. A., Hospenthal, D. R. (2007). Targeted Intranasal Mupirocin To Prevent Colonization and Infection by Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Soldiers: a Cluster Randomized Controlled Trial. Antimicrob. Agents Chemother. 51: 3591-3598 [Abstract] [Full Text]  
• San Juan, R., Chaves, F., Lopez Gude, M. J., Diaz-Pedroche, C., Otero, J., Cortina Romero, J. M., Rufilanchas, J. J., Aguado, J. M. (2007). Staphylococcus aureus poststernotomy mediastinitis: Description of two distinct acquisition pathways with different potential preventive approaches. J. Thorac. Cardiovasc. Surg. 134: 670-676 [Abstract] [Full Text]  
• Kratzer, C., Tobudic, S., Macfelda, K., Graninger, W., Georgopoulos, A. (2007). In Vivo Activity of a Novel Polymeric Guanidine in Experimental Skin Infection with Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 51: 3437-3439 [Abstract] [Full Text]  
• Segers, P., Speekenbrink, R. G. H., Ubbink, D. T., van Ogtrop, M. L., de Mol, B. A. (2007). Chlorhexidine Gluconate for Prevention of Nosocomial Infection in Cardiac Surgery--Reply. JAMA 297: 1060-1060 [Full Text]  
• Shah, S. S., Kagen, J., Lautenbach, E., Bilker, W. B., Matro, J., Dominguez, T. E., Tabbutt, S., Gaynor, J. W., Bell, L. M. (2007). Bloodstream infections after median sternotomy at a children's hospital. J. Thorac. Cardiovasc. Surg. 133: 435-440 [Abstract] [Full Text]  
• Segers, P., Speekenbrink, R. G. H., Ubbink, D. T., van Ogtrop, M. L., de Mol, B. A. (2006). Prevention of Nosocomial Infection in Cardiac Surgery by Decontamination of the Nasopharynx and Oropharynx With Chlorhexidine Gluconate: A Randomized Controlled Trial. JAMA 296: 2460-2466 [Abstract] [Full Text]  
• Nilsson, P., Ripa, T. (2006). Staphylococcus aureus Throat Colonization Is More Frequent than Colonization in the Anterior Nares.. J. Clin. Microbiol. 44: 3334-3339 [Abstract] [Full Text]  
• Karra, R., McDermott, L., Connelly, S., Smith, P., Sexton, D. J., Kaye, K. S. (2006). Risk factors for 1-year mortality after postoperative mediastinitis.. J. Thorac. Cardiovasc. Surg. 132: 537-543 [Abstract] [Full Text]  
• Huang, Y.-C., Chou, Y.-H., Su, L.-H., Lien, R.-I., Lin, T.-Y. (2006). Methicillin-Resistant Staphylococcus aureus Colonization and Its Association With Infection Among Infants Hospitalized in Neonatal Intensive Care Units. Pediatrics 118: 469-474 [Abstract] [Full Text]  
• Shrestha, N. K., Banbury, M. K., Weber, M., Cwynar, R. E., Lober, C., Procop, G. W., Karafa, M. T., Gordon, S. M. (2006). Safety of Targeted Perioperative Mupirocin Treatment for Preventing Infections After Cardiac Surgery. Ann. Thorac. Surg. 81: 2183-2188 [Abstract] [Full Text]  
• Schaffer, A. C., Solinga, R. M., Cocchiaro, J., Portoles, M., Kiser, K. B., Risley, A., Randall, S. M., Valtulina, V., Speziale, P., Walsh, E., Foster, T., Lee, J. C. (2006). Immunization with Staphylococcus aureus Clumping Factor B, a Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model. Infect. Immun. 74: 2145-2153 [Abstract] [Full Text]  
• Fowler, V. G. Jr, O'Brien, S. M., Muhlbaier, L. H., Corey, G. R., Ferguson, T. B., Peterson, E. D. (2005). Clinical Predictors of Major Infections After Cardiac Surgery. Circulation 112: I-358-I-365 [Abstract] [Full Text]  
• Noskin, G. A., Rubin, R. J., Schentag, J. J., Kluytmans, J., Hedblom, E. C., Smulders, M., Lapetina, E., Gemmen, E. (2005). The Burden of Staphylococcus aureus Infections on Hospitals in the United States: An Analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med 165: 1756-1761 [Abstract] [Full Text]  
• Wertheim, H. F. L., Verveer, J., Boelens, H. A. M., van Belkum, A., Verbrugh, H. A., Vos, M. C. (2005). Effect of Mupirocin Treatment on Nasal, Pharyngeal, and Perineal Carriage of Staphylococcus aureus in Healthy Adults. Antimicrob. Agents Chemother. 49: 1465-1467 [Abstract] [Full Text]  
• Fleming, T. R. (2005). Surrogate Endpoints And FDA's Accelerated Approval Process. Health Aff (Millwood) 24: 67-78 [Abstract] [Full Text]  
• Holtfreter, S., Bauer, K., Thomas, D., Feig, C., Lorenz, V., Roschack, K., Friebe, E., Selleng, K., Lovenich, S., Greve, T., Greinacher, A., Panzig, B., Engelmann, S., Lina, G., Broker, B. M. (2004). egc-Encoded Superantigens from Staphylococcus aureus Are Neutralized by Human Sera Much Less Efficiently than Are Classical Staphylococcal Enterotoxins or Toxic Shock Syndrome Toxin. Infect. Immun. 72: 4061-4071 [Abstract] [Full Text]  
• Diekema, D. J., Dodgson, K. J., Sigurdardottir, B., Pfaller, M. A. (2004). Rapid Detection of Antimicrobial-Resistant Organism Carriage: an Unmet Clinical Need. J. Clin. Microbiol. 42: 2879-2883 [Full Text]  
• Wertheim, H. F.L., Vos, M. C., Ott, A., Voss, A., Kluytmans, J. A.J.W., Vandenbroucke-Grauls, C. M.J.E., Meester, M. H.M., van Keulen, P. H.J., Verbrugh, H. A. (2004). Mupirocin Prophylaxis against Nosocomial Staphylococcus aureus Infections in Nonsurgical Patients: A Randomized Study. ANN INTERN MED 140: 419-425 [Abstract] [Full Text]  
• Chambers, H. F. III, Winston, L. G. (2004). Mupirocin Prophylaxis Misses by a Nose. ANN INTERN MED 140: 484-485 [Full Text]  
• Smith, D. L., Dushoff, J., Perencevich, E. N., Harris, A. D., Levin, S. A. (2004). Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: Resistance is a regional problem. Proc. Natl. Acad. Sci. USA 101: 3709-3714 [Abstract] [Full Text]  
• Chaves, F., Garcia-Martinez, J., de Miguel, S., Otero, J. R. (2004). Molecular Characterization of Resistance to Mupirocin in Methicillin-Susceptible and -Resistant Isolates of Staphylococcus aureus from Nasal Samples. J. Clin. Microbiol. 42: 822-824 [Abstract] [Full Text]  
• Saiman, L., Siegel, J. (2004). Infection Control in Cystic Fibrosis. Clin. Microbiol. Rev. 17: 57-71 [Abstract] [Full Text]  
• von Eiff, C., Kokai-Kun, J. F., Becker, K., Peters, G. (2003). In Vitro Activity of Recombinant Lysostaphin against Staphylococcus aureus Isolates from Anterior Nares and Blood. Antimicrob. Agents Chemother. 47: 3613-3615 [Abstract] [Full Text]  
• Holman, W. L., Rayburn, B. K., McGiffin, D. C., Foley, B. A., Benza, R. L., Bourge, R. C., Pinderski, L. J., Kirklin, J. K. (2003). Infection in ventricular assist devices: prevention and treatment. Ann. Thorac. Surg. 75: S48-57 [Abstract] [Full Text]  
• von Eiff, C., Kipp, F., Becker, K., Delgado-Hachmeister, J. E., Graviss, E. A., Perl, T. M., Zimmerman, M. B. (2002). Intranasal Mupirocin to Prevent Postoperative Infections. NEJM 347: 1207-1208 [Full Text]  
• (2002). Do Intranasal Antibiotics Prevent Nosocomial Staphylococcal Infections?. Journal Watch Dermatology 2002: 4-4 [Full Text]  
• (2002). Does Prophylactic Mupirocin Reduce Postoperative S. Aureus Infections?. JWatch Infect. Diseases 2002: 10-10 [Full Text]  
• (2002). Minerva. BMJ 324: 1532-1532 [Full Text]  
• (2002). No Routine Role for Mupirocin Before Surgery. JWatch General 2002: 4-4 [Full Text]  
• Farr, B. M. (2002). Mupirocin to Prevent S. aureus Infections. NEJM 346: 1905-1906 [Full Text]